Chiral LC of a cholesterol-lowering drug using serum albumin mobile phases.
Noroski
J E
JE
Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903-0191, USA.
Mayo
D J
DJ
D000818:Animals; D000924:Anticholesteremic Agents / Q000302:isolation & purification*; D002417:Cattle; D002845:Chromatography / Q000379:methods; D006736:Horses; D006863:Hydrogen-Ion Concentration; D007211:Indoles / Q000302:isolation & purification*; D009943:Organophosphorus Compounds / Q000302:isolation & purification*; D011817:Rabbits; D015203:Reproducibility of Results; D012709:Serum Albumin; D012756:Sheep; D013045:Species Specificity; D013237:Stereoisomerism; D013552:Swine; D013696:Temperature
D000924:Anticholesteremic Agents; D007211:Indoles; D009943:Organophosphorus Compounds; D012709:Serum Albumin; C066279:SQ 33600